From: Current ciprofloxacin usage in children hospitalized in a referral hospital in Paris
Unjustified cipro prescription n (%) | |||
---|---|---|---|
With bacteriological finding | 10 (37.0) | ||
P. aeruginosa | 4 | ||
Intravenous cipro | 4 | ||
Site of infection for P. aeruginosa# | 4 | ||
Multiply susceptible E. coli | 1 | ||
ESBL producing E. coli | 1 | ||
CNS | 4 | ||
Intravenous cipro | 1 | ||
Oral cipro | 5 | ||
Site for non-P. aeruginosa infections$ | |||
Unjustified by antibiogram results | 6 | ||
Unjustified by intravenous cipro in susceptible P. aeruginosa infection | 4 | ||
Without bacteriological finding | 17 (63.0) | ||
Site of non bacteriologically-documented infection | 12 | ||
Pulmonary | 7 | ||
Abdominal | 2 | ||
Catheter related infection | 1 | ||
Operative site infection | 1 | ||
Prophylaxis | 1 | ||
Empiric therapy for fever | 5 | ||
Neutropenia | 1 | ||
Immunocompromised but without Neutropenia | 4 | ||
Unjustified by clinical situation | 17 | ||
Total | 27 (100) |